Skip to main content
CivicGate

HR 2541
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Nuclear Medicine Clarification Act of 2025

To require the Nuclear Regulatory Commission to revise its regulations to protect patients from unintended exposure to radiation during nuclear medicine procedures, and for other purposes.

Introduced Apr 1, 2025

Latest action (Apr 1, 2025) Referred to the House Committee on Energy and Commerce.

Referred to
Energy and Commerce Committee
Policy area
Health
Issues
Healthcare

Summary
  • Requires the Nuclear Regulatory Commission to revise its regulations to clarify reporting requirements for unintended radiation exposure (extravasation) during nuclear medicine procedures.
  • Establishes specific radiation dose thresholds that trigger mandatory reporting of unintended radiation exposure incidents to patients.
  • The NRC must complete the regulation revision within 120 days of enactment, with the revised regulations taking effect 18 months after enactment.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
8 cosponsors

Money behind the sponsor

Top reported contributors to Donald G. Davis’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • Employer not reported $19,150
  • CHARLES AND LYNN SCHUSTERMAN FAMILY PH $13,200
  • BERKSHIRE PARTNERS LLC $11,957
  • GOOGLE $10,906
  • GREYLOCK PARTNERS $9,900

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Donald G. Davis → · Outside spending →

Actions (2)
  1. Apr 1, 2025 Referred to the House Committee on Energy and Commerce. · house
  2. Apr 1, 2025 Introduced in House

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

  • HR 3626 — International Nuclear Energy Act of 2025 · Introduced May 29, 2025 · Cong. 119 68%
  • HR 2504 — The U.S.-European Nuclear Energy Cooperation Act of 2025 · Introduced Mar 26, 2026 · Cong. 119 67%
  • HR 1012 — Spent Fuel Prioritization Act of 2025 · Introduced Feb 5, 2025 · Cong. 119 67%
  • HR 3564 — The Nuclear First-Strike Security Act of 2025 · Introduced May 21, 2025 · Cong. 119 66%
  • HR 475 — Sanction Russian Nuclear Safety Violators Act of 2025 · Introduced Jan 16, 2025 · Cong. 119 65%
  • HR 5000 — Radioprotectant Procurement Act of 2004 · Introduced Aug 2, 2004 · Cong. 108 65%

Text versions (1)
  • Introduced in House · Apr 1, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

April 1, 2025

Mr. Davis of North Carolina (for himself, Mr. Griffith, and Mr. Cline) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To require the Nuclear Regulatory Commission to revise its regulations to protect patients from unintended exposure to radiation during nuclear medicine procedures, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Nuclear Medicine Clarification Act of 2025”.

SEC. 2. MEDICAL EVENT REPORTING OF UNINTENDED IRRADIATION.

(a) Revision of Regulations Required.—Not later than 120 days after the date of enactment of this Act, the Nuclear Regulatory Commission shall revise section 35.3045(a)(1) of title 10, Code of Federal Regulations, by adding at the end the following:

“(iv) A dose that is due to an extravasation and exceeds—

“(A) 0.5 Sv (50 rem) dose equivalent to the 5 cubic centimeter volume of tissue receiving the highest absorbed dose during residence time; or

“(B) 0.5 Sv (50 rem) shallow dose equivalent to the contiguous 10 square centimeters of skin receiving the highest absorbed dose during residence time.”.

(b) Effective Date.—The revision required under subsection (a) shall take effect on the date that is 18 months after the date of enactment of this Act. <all>

Comments

Comments

Loading comments…